Analyst Profile

Followed by 95 followers
.
Carl Byrnes

Carl Byrnes

Northland Securities
Wall Street Analyst
#7,965 out of 8,141 Wall Street Analysts
#23,689 out of 24,284 experts

Success Rate

31%
75 out of 243 transactions made a profit

Average Return

-12.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Carl Byrnes's trades since 2016 and holding each position for 1 Year would result in 30.86% of your transactions generating a profit, with an average return of -12.9% per rating.

Stock Rating Distribution

333Ratings
91.29% Buy
8.71% Hold
0.00% Sell
Distribution of Carl Byrnes's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Tesaro
(TSRO)
Rating:Buy
Date:Feb 05, 2016 - Feb 05, 2017
Return:+362.60%
The most profitable rating made by Carl Byrnes

Carl Byrnes's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
PETX
Aratana
Aug 15, 2016
Hold
Reiterated
2Ratings
0.00%
LJPC
La Jolla Pharma
Aug 15, 2016
Hold
Reiterated
2Ratings
0.00%
TSRO
Tesaro
Sep 06, 2016
Buy
Assigned
2Ratings
100%
+206.05%
Bristol Myers
Oct 22, 2018
Buy
Initiated
$45.00
(-43.95% Downside)
1Ratings
100%
+10.60%
Talos Energy
Oct 22, 2018
Buy
Initiated
1Ratings
0%
-34.90%
MTFB
Motif Bio
Jul 15, 2019
Buy
Assigned
7Ratings
0%
-89.48%
Aytu BioScience
May 14, 2020
Hold
Assigned
12Ratings
78%
+43.43%
GWPH
GW Pharma
May 06, 2021
Hold
Assigned
10Ratings
100%
+87.68%
PolarityTE
May 14, 2021
Buy
Assigned
$3.00
(333.34% Upside)
28Ratings
16%
-56.23%
Heron Therapeutics
Aug 09, 2021
Buy
Reiterated
$35.00
(1191.51% Upside)
28Ratings
14%
-28.20%
List of latest recommendations made by Carl Byrnes. Click to expand and see Carl Byrnes's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >